TERIPARATIDE (BONOTIDE PEN) INJECTION – TREATMENT FOR OSTEOPOROSIS
A synthetic version of the parathyroid hormone called Bonotiode injection is used to treat men and postmenopausal women with severe osteoporosis and a significant risk of fractures. It functions by promoting the growth of new bone, which increases bone density and lowers the risk of spinal fractures.
A healthcare provider should administer the Bonotiode injection intravenously or orally. To get the most out of it, use it frequently and at the same time every day. It is often advised to take it for a maximum of two years.
USES OF TERIPARATIDE (BONOTIDE PEN) INJECTION
WORKS OF TERIPARATIDE (BONOTIDE PEN) INJECTION
A synthetic version of the human hormone parathyroid hormone is known as Bonotiode injection (PTH). It functions by raising bone-forming cells’ activity and population (osteoblasts). By doing so, the risk of fractures is reduced and the bones are strengthened.
SIDE EFFECTS OF TERIPARATIDE (BONOTIDE PEN) INJECTION
- Joint pain
- Injection site reactions (pain, swelling, redness)
- Leg cramps
WARNING & PRECAUTIONS
Bonotiode Injection may make you feel sleepy and lightheaded, less alert, or have an impact on your vision. If you experience these symptoms, don’t drive.
The use of Bonotiode injection during pregnancy may be dangerous. Despite the paucity of human studies, studies on animals have indicated negative consequences on the developing fetus. Before giving you a prescription, your doctor will consider the advantages and any possible hazards. Please speak with your physician.
Fedelty Health Care is a Teriparatide third-party manufacturer, bulk pharma exporter, and pharmaceutical contract manufacturer operating businesses in Venezuela, Saudi Arabia, Cambodia, Oman, Brazil, Lebanon, Chile, Peru, Cuba, and Fiji. Other services they provide are hospital supply, government supply, named patient supply, cold chain supply, and drop shipping.